跳至主要内容
临床试验/NCT05667324
NCT05667324已完成4 期

Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

University of Florida2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年4月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
2
主要终点
Decrease the opioid requirement post-operatively as assessed by providers.

研究概览

简要总结

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the sphenopalatine ganglion using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient presenting for open or endoscopic septorhinoplasty
  • Age 18-80
  • Normal oral food and water intake before surgery
  • ASA physical classification 1-3

排除标准

  • Refusal to consent
  • Patients without a cellular phone or who are unable to accept text messages
  • Allergy to opioid narcotics
  • ASA physical classification of 4 or higher
  • Patient requires other surgery in addition to septorhinoplasty
  • Age > 80 or <18
  • Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months
  • Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
  • Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
  • Pregnant women

研究组 & 干预措施

Group 2: Placebo plus Dexamethasone

Active Comparator

In group 2 the same procedure will be performed, but the injectate will consist of 5 mL of a balanced crystalloid intravenous solution (4 ml of normal saline) plus 4 mg dexamethasone (each side). This procedure will be performed bilaterally.

干预措施: Dexamethasone (Drug)

Group 2: Placebo plus Dexamethasone

Active Comparator

In group 2 the same procedure will be performed, but the injectate will consist of 5 mL of a balanced crystalloid intravenous solution (4 ml of normal saline) plus 4 mg dexamethasone (each side). This procedure will be performed bilaterally.

干预措施: Placebo (Drug)

Group 1: Ropivacaine plus Dexamethasone

Experimental

The group 1 injection procedure will be performed as follows: after preparation of the skin using appropriate skin preparation solution and using aseptic technique, a small-gauge spinal needle will be advanced into the pterygopalatine fossa under ultrasound guidance. Once the needle is properly positioned, 0.5% ropivacaine will be administered at a dose of 20 mg plus 4 mg dexamethasone and the needle will be removed. This procedure will be performed bilaterally

干预措施: Ropivacaine (Drug)

Group 1: Ropivacaine plus Dexamethasone

Experimental

The group 1 injection procedure will be performed as follows: after preparation of the skin using appropriate skin preparation solution and using aseptic technique, a small-gauge spinal needle will be advanced into the pterygopalatine fossa under ultrasound guidance. Once the needle is properly positioned, 0.5% ropivacaine will be administered at a dose of 20 mg plus 4 mg dexamethasone and the needle will be removed. This procedure will be performed bilaterally

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Decrease the opioid requirement post-operatively as assessed by providers.

时间窗: 7 days +/- 2 days

post operative period

Post Operative Pain Scores

时间窗: 5 days +/- 2 days

To assess if bilateral sphenopalatine nerve blocks can decrease post operative pain scores on a scale from 0-10, with a 0 meaning no pain and 10 meaning extreme pain. Pain scores were assessed on post operative days 1, 3 and 5.

次要结局

  • Efficiency of SMS based survey for post-operative data collection.(5 days post-operatively +/- 1 day)
  • Decrease in post-anesthesia care unit observation time.(60-180 minutes)
  • Post Anesthesia Care Unit Duration(60-180 minutes)
  • Text Message Survey Collection(5 days post-operatively +/- 1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验